Registry for early discharge after heart attack treatment

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study collects data from patients with acute coronary syndrome who are discharged early after primary percutaneous coronary intervention (PCI) at a leading cardiac center in London. It aims to gather real-world evidence on the safety and feasibility of the early discharge pathway, analyzing patient characteristics, treatment complications, and outcomes. The study utilizes a password-protected clinical database that includes demographic and clinical data from a large cohort of patients over four years. By investigating these factors, the research seeks to enhance understanding and improve management strategies for coronary artery disease.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Informed consent will not be sought for, as patients are automatically included onto a database that we will use for research purposes. No children will be included in this study. Vulnerable adults or those unable to give consent will be included in the study as well if they are referred to the Interventional Cardiology team.

Both male and female patients ≥16 years of age will be included

All patients will have been admitted to BHC with acute coronary syndrome.

Exclusion Criteria:

Patients \<16 years will not be included in this study.

Where it's running

• Barts Health NHS Trust
  London, United Kingdom Recruiting
• Dr. Daniel Jones
  London, United Kingdom Recruiting

Study contacts

• Study coordinator: Dr. Daniel A Jones
• Email: dan.jones8@nhs.net
• Phone: 02073777000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Comparing imaging techniques for heart artery treatment in heart attack patients

  This study is testing whether using a new imaging technique called optical coherence tomography can help doctors treat heart attack patients better than the traditional method during a procedure to open blocked arteries.

  Recruiting at 18 sites Chonnam National University Hospital · Daegu, Daegu and 17 other locations · NCT06227754

• Using dapagliflozin to reduce heart damage in STEMI patients

  This study is testing if the medication dapagliflozin can help reduce heart damage in patients who have just had a heart attack and are receiving treatment.

  Recruiting Phase 3 Ottawa Heart Institute Research Corporation · Ottawa, Ontario · NCT06174753

• Comparing IVUS and FFR for treating artery lesions in heart attack patients

  This study is testing whether using ultrasound or a different method to guide treatment for blocked arteries helps heart attack patients with multiple affected vessels get better results after their initial procedure.

  Recruiting Samsung Medical Center · Gwangju and 1 other locations · NCT05812963

• Heart@Home: Safe, at-home care for people with acute heart problems compared with hospital care

  This trial tests whether hospital-level care at home can safely and effectively treat adults with acute heart conditions who would normally be in the hospital.

  Recruiting Tel-Aviv Sourasky Medical Center · Tel Aviv · NCT07913152

• Digital cardiac rehab to help heart attack patients improve function

  A digital health–supported cardiac rehabilitation program is being tested to see if it helps people after a heart attack improve fitness and stay engaged with rehab, compared with standard outpatient rehab.

  Recruiting Cairo University · Minya, Minya Province · NCT07867197

• NMR-based Risk Test and Digital Health Support for midlife adults in Eloisa

  This study tests whether an NMR metabolomics risk test can guide tailored digital health programs for midlife adults at risk of diabetes, heart disease, stroke, kidney disease, or fatty liver.

  Recruiting University of Eastern Finland · Savonlinna · NCT07820800

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.